Associations between circulating mtDNA and NLRP3 are also emerging, with potential as biomarkers of NLRP3 activation and increased levels of cell‐free circulating mtDNA have been linked to a poor prognosis in patients with COVID‐19.63 This evidence concerns the gene NLRP3 and COVID-19.